Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ptafrem1/Cya
Common Name:
Ptafr-KO
Product ID:
S-KO-03834
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ptafr-KO
Strain ID
KOCMP-19204-Ptafr-B6J-VA
Gene Name
Ptafr
Product ID
S-KO-03834
Gene Alias
PAFR
Background
C57BL/6JCya
NCBI ID
19204
Modification
Conventional knockout
Chromosome
4
Phenotype
MGI:106066
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ptafrem1/Cya mice (Catalog S-KO-03834) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000070690
NCBI RefSeq
NM_001081211
Target Region
Exon 2
Size of Effective Region
~1.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ptafr, the platelet-activating factor receptor, is a crucial component in various biological processes. Platelet-activating factor (PAF) is a phospholipid-derived inflammatory mediator, and Ptafr is the receptor through which PAF exerts its pro-inflammatory, pro-coagulant, and angiogenic actions on the vasculature [4]. The PAF/Ptafr pathway is involved in multiple disease-related processes, such as inflammation, metastasis, and angiogenesis [5,6]. Genetic models are valuable for studying Ptafr's functions.

In a TP53/CDKN2A double-knockout gastroesophageal junction organoid model, inactivation of these tumor suppressor genes up-regulated PTAF and its receptor PTAFR. Abrogation of PTAFR by siRNA knockdown or a pharmacologic inhibitor reduced proliferation and proneoplastic features both in vitro and in vivo, revealing its role in promoting tumorigenesis [1]. In an atherosclerosis study, bioinformatics analysis and validation experiments identified PTAFR as a key gene regulating neutrophil extracellular traps (NETs) formation, impacting the progression and prognosis of atherosclerosis [2]. In cardiac fibrosis research, knockdown of PTAFR affected the pro-fibrotic collagen production mediated by the lncRNA PFL, and its overexpression also led to collagen production [3].

In conclusion, Ptafr plays essential roles in tumorigenesis, atherosclerosis, and cardiac fibrosis. Gene-knockout models have been instrumental in uncovering these functions, providing insights into the molecular mechanisms underlying these diseases and suggesting Ptafr as a potential therapeutic target for related disease treatment.

References:

1. Zhao, Hua, Cheng, Yulan, Kalra, Andrew, Lin, De-Chen, Meltzer, Stephen J. 2022. Generation and multiomic profiling of a TP53/CDKN2A double-knockout gastroesophageal junction organoid model. In Science translational medicine, 14, eabq6146. doi:10.1126/scitranslmed.abq6146. https://pubmed.ncbi.nlm.nih.gov/36449602/

2. Ye, Chaowen, Zhao, Yunli, Yu, Wei, Huang, Rongzhong, Hu, Tianyang. 2024. Identifying PTAFR as a hub gene in atherosclerosis: implications for NETosis and disease progression. In Human genomics, 18, 139. doi:10.1186/s40246-024-00708-3. https://pubmed.ncbi.nlm.nih.gov/39709510/

3. Leisegang, Matthias S. 2018. LET's sponge: How the lncRNA PFL promotes cardiac fibrosis. In Theranostics, 8, 874-877. doi:10.7150/thno.23364. https://pubmed.ncbi.nlm.nih.gov/29463987/

4. Bhosle, Vikrant K, Rivera, José Carlos, Zhou, Tianwei Ellen, Ribeiro-da-Silva, Alfredo, Chemtob, Sylvain. 2016. Nuclear localization of platelet-activating factor receptor controls retinal neovascularization. In Cell discovery, 2, 16017. doi:10.1038/celldisc.2016.17. https://pubmed.ncbi.nlm.nih.gov/27462464/

5. Cao, Linna, Zhang, Yiwei, Mi, Jinxia, Pan, Zhiqiang, Peng, Peike. 2022. α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression. In Pharmacological research, 178, 106180. doi:10.1016/j.phrs.2022.106180. https://pubmed.ncbi.nlm.nih.gov/35288308/

6. Hou, Tianhui, Lou, Yan, Li, Shichang, Li, Zhenxi, Xiao, Jianru. 2018. Kadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway. In Oncology letters, 16, 2255-2262. doi:10.3892/ol.2018.8935. https://pubmed.ncbi.nlm.nih.gov/30008927/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest